Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Genentech Gains Modular Engineered Antibodies in $5B Deal

Natural killer cell

A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal

Baby Box Technology for Sick Newborns Licensed to Start-Up

Newborn in incubator

A start-up company is gaining the rights to a technology that helps the breathing of infants suffering from withdrawal from drugs taken by their mothers, and other disruptive conditions. . . . → Read More: Baby Box Technology for Sick Newborns Licensed to Start-Up

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Allergan Licensing Crispr for Inherited Eye Disease

Editing DNA

Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease

Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

Neurons

A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

Merck, Biopharma Partner on Cell-Free Immune System Therapies

Cancer magnified

Drug maker Merck is acquiring the rights to therapies for cancer and autoimmune disorders based on a technology for developing synthetic proteins from a process that bypasses live cells. . . . → Read More: Merck, Biopharma Partner on Cell-Free Immune System Therapies

Exosome Technology Acquired for TBI, Stroke Therapies

Stroke circulation

A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes. . . . → Read More: Exosome Technology Acquired for TBI, Stroke Therapies

Engineered Polio Virus Tested as Brain Cancer Treatment

Brain tumor graphic

Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research